Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials

Background Low serum levels of 25-hydroxyvitamin D have been associated with worse outcomes in multiple sclerosis (MS) patients treated with interferon-beta. Association of vitamin D nutrition on the outcomes of other MS therapies has been studied less. Objective Whether patients in the phase 3 fing...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of neurology Vol. 265; no. 2; pp. 348 - 355
Main Authors:	Hongell, Kira, Silva, Diego G., Ritter, Shannon, Meier, Daniela Piani, Soilu-Hänninen, Merja
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2018 Springer Nature B.V
Subjects:	25-Hydroxyvitamin D Clinical trials Dietary supplements Gadolinium Lesions Magnetic resonance imaging Medicine & Public Health Multiple sclerosis Neurology Neuroradiology Neurosciences Original Communication Patients Serum levels Vitamin D β-Interferon Vitamin D Fingolimod MRI MS EDSS
ISSN:	0340-5354, 1432-1459, 1432-1459
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!